Original Article

Journal of Investigative Dermatology (1992) 98, 241–247; doi:10.1111/1523-1747.ep12556058

Neutrophil-Activating Proteins in Psoriasis

Jens-M Schröder1, Harry Gregory2, Janice Young2 and Enno Christophers1

  1. 1Department of Dermatology, University of Kiel, Kiel, Germany
  2. 2Imperial Chemical Industries, Pharmaceuticals Division, Macclesfield, U.K.

Received 17 May 1991; Accepted 19 July 1991.

Top

Abstract

Neutrophil accumulation in the epidermis is a histologic characteristic of psoriasis. We addressed the question: What is the major protein-like chemotactic principle responsible for neutrophil accumulation? Purification of proteinaceous neutrophil chemoattractants from extracts obtained from psoriatic scales by multistep high-performance liquid chromatography (HPLC) yielded three biochemically distinct polypeptides with potent neutrophil chemotactic activity. Aminoterminal amino acid sequence analysis of the quantitatively major neutrophil attractant revealed the sequence ELRXQXIKTYSK, which is identical to that of a 69 residue form of neutrophil-activating peptide-1/interleukin 8 (NAP-1/IL-8). The second major attractant showed the sequence XXVATELRXQXL ..., which is identical to that of the gene product of the oncogene "gro" as well as "melanoma growth stimulatory activity, MGSA," whereas the third and minor neutrophil chemotaxin has an NH2-terminal sequence identical with NAP-1/IL-8. Estimation of NAP-1/IL-8-related proteins and gro/MGSA by HPLC combined with bioassay revealed a mean of 3.3 plusminus 1.7 ng NAP-1/IL-8-related proteins (n = 11) and 3.2 plusminus 1.9 ng gro/MGSA (n = 11) per 1 mg psoriatic scales. In normal heel callus (n = 8), these neutrophil attractants were found at concentrations below 0.02 plusminus 0.01 ng/mg. The finding of more than 150-times increased amounts of both NAP-1/IL- 8 and gro/MGSA in lesional psoriasis material suggest that these mitogenic as well as neutrophil- and lymphocyte-chemotactic compounds may play an important role in the pathogenesis of psoriasis.

Top

References

  1. Christophers, E, Krueger, G: Psoriasis. In: Fitzpatrick TB, Eisen AC, Wolff K, Freedberg EM, Austen KF (eds.). Dermatology in General, Medicine 1986 McGraw-Hill Book Co., New York, pp 461–491,
  2. Braun-Falco, O, Christophers, E: Structural aspects of initial psoriatic lesions. Arch Derm Forsch 1974 251: 95–110,  | ChemPort |
  3. Schröder, JM, Christophers, E: Identification of C5adesarg and an anionic neutrophil activating peptide (ANAP) in psoriatic scales. J Invest Dermatol 1986 87: 53–58,  | PubMed |
  4. Schröder, JM, Mrowietz, U, Morita, E, Christophers, E: Purification and partial biochemical characterization of a human monocyte-derived. neutrophil activating peptide that lacks lnterleukin 1 activity. J Immunol 1987 139: 3474–3483,  | PubMed | ISI | ChemPort |
  5. Creamer, HR, Gabler, WL, Bullock, WW: Endogenous component chemotactic assay (ECCA). Inflammation 1983 7: 321–332,  | Article | PubMed | ChemPort |
  6. Schägger, H, Jagow, GV: Tricine-sodinm dodecylsulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kD. Anal Biochem 1987 166: 368–379,  | Article | PubMed | ISI | ChemPort |
  7. Kratzin, HD, Wiltfang, J, Karras, M, Neuboff, V, Hilschmann, N: Gas phase sequencing after electroblotting on polyvinylidene difluoride membranes signs correct molecular weights to myoglobin molecular weight markers. Anal Biochem 1989 183: 1–8,  | Article | PubMed | ChemPort |
  8. Richmond, A, Balentien, E, Thomas, HG: Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta-thromboglobulin. EMBO J 1988 7: 2025–2033,  | PubMed | ISI | ChemPort |
  9. Tagami, H, Ofuji, S: Characterization of a leukotactic factor derived from psoriatic scale. Br J Dermatol 1977 97: 509–518,  | PubMed | ChemPort |
  10. Brain, SD, Camp, RDR, Dawd, PM: Leukotriene B4 and monohydroxyeicosatetracnoic acid like material are released in biologically active amounts from the lesional skin of patients with psoriasis. Br J Pharmacol 1983 83: 313–317,  | ISI |
  11. Mallet, AI, Cunningham, FM, Daniel, R: Rapid isocratic high performance liquid Chromatographic purification of platelet activating factor (PAF) and lyso-PAF from human skin. J Chromatogr 1984 309: 160–164,  | PubMed | ISI | ChemPort |
  12. Camp, RDR, Fincham, NJ, Cunningham, EM, Greaves, MW, Morris, J, Chu, A: Psoriatic skin lesions contain biologically active amounts of an interleukin-1-like compound. J Immunol 1986 137: 3469–3474,  | PubMed | ChemPort |
  13. Sauder, DN, Mounessa, NL, Katz, SI, Dinarello, CA, Gallin, JI: Chemotactic cytokines: the role of leukotactic pyrogen and epidermal cell thymocyte activating factor in neutrophil chemotaxis. J Immunol 1984 132: 828–832,  | PubMed | ISI | ChemPort |
  14. Luger, TA, Charon, JA, Colot, M, Micksche, M, Oppenheim, JJ: Chemotactic properties of partially purified human epidermal cellderived thymocyte activating factor (ETAF) for polymorphonuclear and mononuclear cells. J Immunol 1983 131: 816–820,  | PubMed | ChemPort |
  15. Georgilis, K, Schäfer, C, Dinarello, CA, Klempner, MS: Human recombinant Interleukin 1beta has no effect on intracellular calcium or on functional responses of human neutrophils. J Immunol 1987 139: 3403–3407,
  16. Fincham, NJ, Camp, RDR, Gearing, AJH, Bird, CR, Cunningham, FM: Neutrophil chemoattractant and IL-1-like activity in samples from psoriatic lesions: further characterization. J Immunol 1988 140: 4294–4299,  | PubMed | ChemPort |
  17. Mrowietz, U, Schröder, JM, Morita, E, Ternowitz, T, Christophers, E: A psoriatic scale-derived chemotactic peptide (ANAP) is a specific activator of neutrophil functions (abstr). J Invest Dermatol 1987 89: 330,
  18. Gronhoj Larsen, C, Anderson, AO, Appella, E, Oppenheim, JJ, Matsushima, K: The neutrophil activating protein (NAP-1) is also chemotactic for T-lymphocytes. Science 1989 243: 1464–1466,  | PubMed |
  19. Baggiolini, M, Walz, A, Kunkel, SL: Neutrophil activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 1989 84: 1045–1049,  | PubMed | ISI | ChemPort |
  20. Matsushima, K, Oppenheim, JJ: Novel inflammatory cytokines inducible by IL-1 and TNF. Cytokine 1990 1: 2–13,
  21. Leonard, EJ, Yoshimura, T: Neutrophil attractant-activation protein-1 (NAP-1) [interleukin-8]. Ann J Respir Cell Mol Biol 1990 2: 479–486,  | ChemPort |
  22. Anisowicz, A, Bardwell, L, Säger, R: Constitutive over expression of a growth regulated gene in transformed Chinese hamster and human cells. Proc Nad Acad Sci USA 1987 84: 7188–7192,  | ChemPort |
  23. Schröder, JM, Christophers, E: Secretion of novel and homologous neutrophil activating peptides by LPS-stimulated human endothelial cells. J Immunol 1989 142: 244–251,  | PubMed | ISI | ChemPort |
  24. Schröder, JM, Sticherling, M, Henneicke, HH, Preissner, WC, Christophers, E: IL-1alpha or TNFalpha stimulated release of three IL-8-related neutrophil chemotactic proteins in human dermal fibroblasts. J Immunol 1990 144: 2223–2332,  | PubMed | ChemPort |
  25. Schröder, JM, Persoon, NL, Christophers, E: Lipopolysaccharide stimulated human monocytes secrete apart from NAP-1/IL-8 a second neutrophil activating protein: NH2-terminal amino acid sequence identity with melanoma growth stimulatory activity (MGSA/gro). J Exp Med 1990 171: 1091–1100,  | Article | PubMed | ChemPort |
  26. Moser, B, Clark-Lewis, I, Zwahlen, R, Baggiolini, M: Neutrophil-activating properties of the melanoma growth-stimulatory activity. J Exp Med 1990 171: 1797–1802,  | Article | PubMed | ISI | ChemPort |
  27. Schröder, JM, Christophers, E: Human melanoma growth stimulating activity (MGSA/gro) is a neutrophil activator. In: Oppenheim JJ, Prowanda MC, Kluger MJ, Dinarello CA (eds.). Molecular and Cellular Biology of Cytokines. Progress in Leukocyte Biology 1990 10A: Wiley Inc., New York, pp 351–356,
  28. Lindley, IJD, Aschauer, H, Lam, C, Besemer, J, Rot, A: In vitro and in vivo activity of mutagenized versions of recombinant human NAP1/IL-8 and identification of functionally important domenes. In: Oppenheim JJ, Prowanda MC, Kluger MJ, Dinarello CA (eds.). Molecular and Cellular Biology of Cytokines. Progress in Leukocyte Biology 1990 10a: Wiley Inc., New York, pp 345–350,
  29. Gearing, AJ H, Fincham, NJ, Bird, CR, Wadhwa, M, Meager, A, Cartwright, JE, Camp, RDR: Cytokines in skin lesions of psoriasis. Cytokine 1990 2: 68–75,  | Article | PubMed | ChemPort |
  30. Schröder, JM, Christophers, E: Identification of a novel family of highly potent neutrophil chemotactic peptides in psoriatic scales (abstr). J Invest Dermatol 1988 91: 395,
  31. Sticherling, M, Schröder, JM, Christophers, E: Lack of biologically active interleukin 8 in normal skin (abstr). J Invest Dermatol 1990 95: 491,
  32. Richmond, A, Thomas, HG: Melanoma growth stimulatory activity: isolation from human melanoma tumors in characterization of tissue distribution. J Cell Biochem 1988 36: 185–198,  | Article | PubMed | ISI | ChemPort |
  33. Leonard, EJ, Skeel, A, Yoshimura, T, Noer, N, Kutvird, S, Van Epps, DE: Leukocyte specificity and binding of neutrophil attractant/activation protein-1. J Immunol 1990 144: 1323–1331,  | PubMed | ChemPort |
  34. Leonard, EJ, Yoshimura, T, Tanaka, S, Raffeld, M: Neutrophil recruitment by intradermally injected neutrophil attractant-/activating protein-1 (NAP-1) in human subjects. J Invest Dermatol 1991 96: 690–694,  | Article | PubMed | ISI | ChemPort |
  35. Swensson, O, Schubert, C, Christophers, E, Schröder, JM: Inflammatory properties of neutrophil activating protein-1/Interleukin 8 (NAPl/IL-8) in human skin. A light- and elcctronmicroscopic study. J Invest Dermatol 1991 96: 682–689,  | Article | PubMed | ISI | ChemPort |
  36. Schröder, JM: The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate 5-lipoxygenase but not the release of cellular arachidonate. J Exp Med 1989 170: 847–863,  | PubMed |
  37. Hammarström, SM, Hamberg, M, Samuelsson, B, Duell, E, Stawski, M, Voorhees, JJ: Increased concentrations of non-esterified arachidonic acid 12-L-hydroxy-5,8,10,14-eicosatctracnoic acid, prostaglandin E2 and prostaglandin F2 in epidermis of psoriasis. Proc Nad Acad Sci USA 1975 72: 5130–5134,
  38. Larsen, CG, Anderson, AO, Oppenheim, JJ, Matsushima, K: Production of Interleukin 8 by human dermal fibroblasts and keratinocytes in response to Interleukin 1 or tumor necrosis factor. Immunology 1989 68: 31–38,  | PubMed | ISI | ChemPort |
  39. Golds, EE, Mason, PP, Nyirkos, P: Inflammatory cytokines induce synthesis and secretion of gro protein and an neutrophil chemotactic factor but not beta2-microglobulin in human synovial cells and fibroblasts. Biochem J 1989 259: 585–588,  | PubMed | ISI | ChemPort |
  40. Van Damme, J, Decock, B, Bonings, R, Lenaerts, JP, Opdenakker, G, Billiau, A: The chemotactic activity for granulocytes produced by virally infected fibroblasts is identical to monocyte-derived Interleukin-8. Eur J Immunol 1989 19: 1189–1194,  | PubMed | ChemPort |
  41. Strieter, R, Phan, SH, Showell, HJ: Monokine-induced neutrophil chemotactic factor gene expression in human fibroblasts. J Biol Chem 1989 264: 10621–10626,  | PubMed | ChemPort |
  42. Barker, JNWN, Sana, V, Mitra, RS, Dixit, VM, Nickoloff, BJ: Market synergism between tumor necrosis factor alpha and interferon in regulation of keratinocyte-derived adhesion molecules and chemotactic factors. J Clin Invest 1990 85: 605–608,  | PubMed | ISI | ChemPort |
  43. Nickoloff, BJ, Karabin, GD, Barker, JNWN: Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am J Pathol 1991 138: 129–140,  | PubMed | ISI | ChemPort |
  44. Gillitzer, R, Berger, R, Mielke, V, Wolff, K, Stingl, G: Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1/IL-8 mRNA in situ. J Invest Dermatol 1991 97: 73–79,  | Article | PubMed | ISI | ChemPort |
  45. Castor, CW, Miller, JW, Walz, DA: Structural and biological characteristics of connective tissue activating peptide (CTAP III), a major human platelet-derived growth factor. Proc Natl Acad Sci USA 1983 80: 765–769,  | Article | PubMed | ChemPort |

Extra navigation

.
ADVERTISEMENT